How Hims & Hers Is Reshaping Everyday Wellness — TradingView News

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, continues to shape the future of health and wellness by integrating clinical excellence with a consumer-first digital platform. Offering accessible treatment for chronic and sensitive conditions such as mental health, dermatology, sexual wellness and weight management, the company has delivered over 30 million telehealth consultations across the United States and the U.K.

HIMS’ mobile applications also extend beyond medical treatment, offering users personalized wellness content, education and community support — fostering a holistic and lifelong approach to well-being. This strategy is tightly aligned with the latest global trends.

According to McKinsey’s 2025 Future of Wellness Trends survey, wellness has become a central focus in consumers’ lives, particularly among younger generations, such as Gen Z and millennials. The report emphasizes the growing demand for accessible, science-backed and personalized solutions across categories such as mental health, weight management and functional health. In response, Hims & Hers has expanded its capabilities in compounded medications, lab testing and personalized digital care. As the wellness industry continues to evolve, Hims & Hers stands out for its scalable, tech-enabled model that delivers individualized care and proactive health management in a streamlined, user-centric format.

LFMD & MED’s Lifestyle-Driven Innovation in Digital Health and Wellness

LifeMD, Inc. LFMD is a direct-to-patient telehealth company specializing in virtual and in-home care across a growing portfolio of lifestyle and chronic health conditions. LifeMD provides accessible treatment for weight management, sexual wellness, hormone therapy and primary care through asynchronous and live visits. The company’s proprietary technology platform supports recurring prescription plans and over-the-counter wellness offerings under brands like ShapiroMD. LifeMD continues to expand its services and infrastructure, reinforcing its commitment to accessible, personalized digital healthcare nationwide.

Medifast, Inc. MED is a leading health and wellness company focused on lifestyle-based weight management through its OPTAVIA program. Medifast offers habit-driven, coach-supported plans designed to help individuals adopt long-term healthy behaviors. The company supports over 25,000 active earning OPTAVIA coaches and has impacted more than 3 million lives. With recent expansion into GLP-1 medication support through a collaboration with LifeMD, Medifast now caters to users both on and off pharmacological therapies. Its science-backed offerings and personalized coaching approach place Medifast at the forefront of evidence-based wellness solutions.

HIMS’ Price Performance, Valuation and Estimates

Shares of Hims & Hers have gained 90.6% year to date, outperforming the industry’s growth of 9.9%.

Zacks Investment Research

HIMS’ forward 12-month P/S of 4.1X is lower than the industry’s average of 5.8X, but is higher than its three-year median of 2.3X. It carries a Value Score of C.

The Zacks Consensus Estimate for HIMS’ 2025 earnings per share suggests a 174.1% improvement from 2024.

Zacks Investment Research

Hims & Hers stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Source link

Visited 1 times, 1 visit(s) today

Related Article

Sonay Kartal of Britain reacts after losing a point against Russia's Anastasia Pavlyuchenkova during a fourth round

Wimbledon: Another electronic line-call blunder comes in Taylor Fritz’s quarter-final win over Karen Khachanov | Tennis News

Wimbledon suffered another electronic line call malfunction caused by the movement of a ball boy during Taylor Fritz’s quarter-final victory over Karen Khachanov on Tuesday.  Swedish umpire Louise Azemar-Engzell called ‘stop’ in the opening game of the fourth set on Court One when ‘fault’ was incorrectly announced after a Fritz forehand landed well inside the baseline.

image

EUR/USD Signal Today 08/07: To Retest 1.1565 (chart)

Bearish view Sell the EUR/USD pair and set a take-profit at 1.1565. Add a stop-loss at 1.1950. Timeline: 1-3 days. Bullish view Buy the EUR/USD pair and set a take-profit at 1.1950. Add a stop-loss at 1.1565. The EUR/USD exchange rate remained in a tight range after the latest European retail sales data. It was

Article image:Sunderland sign Champions League defender from Atletico

Sunderland sign Champions League defender from Atletico

Sunderland Make Statement Signing with Reinildo Mandava Arrival Sunderland have made a bold move in the transfer market, securing the services of left-back Reinildo Mandava from Atletico Madrid. The Mozambique international arrives at the Stadium of Light on a two-year deal, bringing with him not only LaLiga and Champions League pedigree, but the kind of

China Allegedly Copied Dozens of Russian Weapons Systems Through Espionage and Cyberattacks

Chinese Warship Blinds German Recon Jet With Laser During EU Red Sea Mission — UNITED24 Media

Germany has formally accused China of endangering its personnel by targeting a German reconnaissance aircraft with a military-grade laser during an EU naval mission near Yemen, according to a statement issued by the Federal Foreign Office on July 8. The incident occurred during Operation ASPIDES, the European Union’s maritime security mission in the Red Sea, which aims to protect international shipping from attacks by Yemen’s Houthi rebels. Germany reported

Markets Unfazed by Trump Tariff Letters; Kiwi Outshone by Aussie ahead of RBNZ Hold

Global equity markets traded cautiously and remained stable on Tuesday, showing limited reaction to escalating US trade threats. Major European indexes moved in narrow ranges following modest gains in Asia, while US equity futures stayed flat. The restrained response suggests markets are neither complacent nor panicked as they assess the credibility and timing of new

Access Denied

Access Denied You don’t have permission to access “http://www.telegraph.co.uk/business/2025/07/08/trumps-art-of-the-deal-is-breaking-xis-grip-on-asia/” on this server. Reference #18.ea22717.1751993068.68059e24 https://errors.edgesuite.net/18.ea22717.1751993068.68059e24

0
Would love your thoughts, please comment.x
()
x